More about

Atherosclerotic Cardiovascular Disease

News
February 17, 2025
4 min read
Save

AACE guidance examines medication options for preventing ASCVD in adults with dyslipidemia

AACE guidance examines medication options for preventing ASCVD in adults with dyslipidemia

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting newer medications that could be added to statin therapy or used on patients intolerant to statins.

News
January 28, 2025
3 min read
Save

Certain low-risk populations continue baby aspirin use, despite risk and clinical guidance

Certain low-risk populations continue baby aspirin use, despite risk and clinical guidance

Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent clinical guidance, researchers found.

News
December 18, 2024
2 min read
Save

Millions of American adults face a 10% or higher risk for heart failure

Millions of American adults face a 10% or higher risk for heart failure

As many as 15 million adults in the United States have a 10% or greater risk for heart failure, results of a research letter published in Annals of Internal Medicine showed.

News
November 27, 2024
2 min read
Save

Lesbian, gay, bisexual veterans face higher odds for prevalent ASCVD vs. straight peers

Lesbian, gay, bisexual veterans face higher odds for prevalent ASCVD vs. straight peers

Lesbian, gay and bisexual U.S. veterans had significantly higher odds for prevalent atherosclerotic CVD compared with their heterosexual peers, according to findings published in the Journal of the American Heart Association.

News
November 26, 2024
2 min read
Save

Novel injectable agent lowers Lp(a) by more than 80% at 36 weeks

Novel injectable agent lowers Lp(a) by more than 80% at 36 weeks

CHICAGO — Zerlasiran, a novel injectable small interfering RNA molecule, lowered lipoprotein(a) by more than 80% compared with placebo at 36 weeks, according to the results of the ALPACAR trial.

News
October 21, 2024
3 min watch
Save

VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”

News
October 08, 2024
3 min read
Save

Having three or more metabolic risk factors raises diabetes risk in people with HIV

Having three or more metabolic risk factors raises diabetes risk in people with HIV

In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.

News
October 01, 2024
3 min read
Save

FDA clears software to reduce ‘guesstimation’ when assessing atherosclerotic risk

FDA clears software to reduce ‘guesstimation’ when assessing atherosclerotic risk

Elucid announced it received 510(k) clearance from the FDA for its noninvasive imaging analysis software to help quantify and classify plaque morphology and diagnose CVD.

News
August 14, 2024
2 min read
Save

Adults with type 2 diabetes improve HbA1c, medication use with pharmacist referral

Adults with type 2 diabetes improve HbA1c, medication use with pharmacist referral

Adults with type 2 diabetes who are referred to a clinical pharmacist are more likely to meet their HbA1c goal and receive appropriate medication management of comorbidities than people receiving usual care, according to a presenter.

News
August 12, 2024
2 min read
Save

SGLT2 inhibitors greatly underprescribed in patients who qualify for them

SGLT2 inhibitors greatly underprescribed in patients who qualify for them

In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.

View more